Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15,369Revenue $M11,764Net Margin (%)5.4Z-Score2.0
Enterprise Value $M22,795EPS $3.0Operating Margin %13.2F-Score6
P/E(ttm))19.6Cash Flow Per Share $8.2Pre-tax Margin (%)9.6Higher ROA y-yY
Price/Book3.310-y EBITDA Growth Rate %15.5Quick Ratio1.4Cash flow > EarningsY
Price/Sales1.35-y EBITDA Growth Rate %16.0Current Ratio1.4Lower Leverage y-yY
Price/Cash Flow13.1y-y EBITDA Growth Rate %44.4ROA % (ttm)3.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)14.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M214ROI % (ttm)3.4Gross Margin Increase y-yN

Gurus Latest Trades with DVA

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DVAMario Gabelli 2014-03-31 Buy 0.01%$62.74 - $69.81
($66.3)
$ 71.468%New holding, 26583 sh.26,583
DVASteve Mandel 2014-03-31 Reduce-1.31%$62.74 - $69.81
($66.3)
$ 71.468%Reduce -56.84%3,655,739
DVARay Dalio 2014-03-31 Reduce-0.01%$62.74 - $69.81
($66.3)
$ 71.468%Reduce -30.5%64,941
DVASteve Mandel 2013-12-31 Add0.59%$55.03 - $63.39
($58.62)
$ 71.4622%Add 34.41%8,470,777
DVAWarren Buffett 2013-12-31 Add0.3%$55.03 - $63.39
($58.62)
$ 71.4622%Add 15.95%36,461,294
DVAJoel Greenblatt 2013-12-31 Add0.21%$55.03 - $63.39
($58.62)
$ 71.4622%Add 171.1%221,775
DVARichard Perry 2013-12-31 Sold Out -0.36%$55.03 - $63.39
($58.62)
$ 71.4622%Sold Out0
DVARon Baron 2013-12-31 Sold Out -0.16%$55.03 - $63.39
($58.62)
$ 71.4622%Sold Out0
DVAJohn Burbank 2013-12-31 Sold Out -0.01%$55.03 - $63.39
($58.62)
$ 71.4622%Sold Out0
DVASteve Mandel 2013-09-30 Buy 1.6%$53.755 - $60.615
($57.24)
$ 71.4625%New holding, 6302027 sh.6,302,027
DVARichard Perry 2013-09-30 Buy 0.36%$53.755 - $60.615
($57.24)
$ 71.4625%New holding, 250000 sh.250,000
DVARon Baron 2013-09-30 Buy 0.16%$53.755 - $60.615
($57.24)
$ 71.4625%New holding, 600000 sh.600,000
DVAJoel Greenblatt 2013-09-30 Add0.13%$53.755 - $60.615
($57.24)
$ 71.4625%Add 668.57%81,807
DVARay Dalio 2013-09-30 Add0.03%$53.755 - $60.615
($57.24)
$ 71.4625%Add 292.11%89,400
DVAJohn Burbank 2013-09-30 Buy 0.01%$53.755 - $60.615
($57.24)
$ 71.4625%New holding, 4410 sh.4,410
DVAJohn Keeley 2013-09-30 Sold Out $53.755 - $60.615
($57.24)
$ 71.4625%Sold Out0
DVAJulian Robertson 2013-09-30 Sold Out -1.9%$53.755 - $60.615
($57.24)
$ 71.4625%Sold Out0
DVAJoel Greenblatt 2013-06-30 Buy 0.03%$58.66 - $65.6
($62.44)
$ 71.4614%New holding, 5322 sh.5,322
DVASteve Mandel 2013-06-30 Sold Out -1.2%$58.66 - $65.6
($62.44)
$ 71.4614%Sold Out0
DVAJulian Robertson 2013-06-30 Reduce-0.26%$58.66 - $65.6
($62.44)
$ 71.4614%Reduce -11.69%120,900
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DVA is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
DVA Mario Gabelli 2014-03-3126,5830.010.01New Buy
DVA Warren Buffett 2014-03-3137,621,15217.562.4+3.18%
DVA Joel Greenblatt 2014-03-31217,2150.10.23-2.06%
DVA Ray Dalio 2014-03-3164,9410.030.04-30.5%
DVA Steve Mandel 2014-03-313,655,7391.711.1-56.84%
Premium Most recent portfolio changes are included for Premium Members only!


DVA: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
JIGANTI JEANINE MARIEChief Compliance Officer 2014-07-10Sell303$72.97-2.07view
Rivera Kim MChief Legal Officer 2014-06-11Sell5,929$71.050.58view
HILGER JAMES KChief Accounting Officer 2014-06-09Sell466$71.89-0.6view
Mildenberger LauraChief People Ofcr, Kidney Care 2014-05-29Sell5,080$69.992.1view
THIRY KENT JCo-Chairman & CEO 2014-05-16Sell17,600$67.416.01view
Kogod DennisCOO, HealthCare Partners 2014-05-16Sell18,750$67.36.18view
ZUMWALT LEANNE MGrp VP Purch & Public Affairs 2014-05-16Sell245$67.36.18view
HILGER JAMES KChief Accounting Officer 2014-05-15Sell1,666$67.236.29view
Rodriguez JavierCEO, Kidney Care 2014-05-15Sell7,000$67.55.87view
Kogod DennisCOO, HealthCare Partners 2014-05-12Sell32,188$68.065view

Press Releases about DVA :

    Quarterly/Annual Reports about DVA:

    News about DVA:

    Articles On GuruFocus.com
    Warren Buffett's 3 High-Conviction Stocks Jun 13 2014 
    Thoughts on Ted Weschler's Largest Holding and Excellent Long-Term Results Mar 14 2014 
    Buffett's Investor Pick Ted Weschler Discusses DaVita Inc. Mar 03 2014 
    Three Billionaires Adjust Portfolio Holdings – Buffett, Watsa and Loeb Feb 28 2014 
    Manning & Napier New Stocks of Fourth Quarter Jan 29 2014 
    What the Gurus Bought this Week Dec 13 2013 
    Why Warren Buffett's Successor Likes DaVita So Much Dec 12 2013 
    Warren Buffett Added This Helathcare Stock Twice in One Month Dec 11 2013 
    Warren Buffett’s Berkshire Increases Stake in DaVita HealthCare Partners Dec 10 2013 
    Baron Funds Comments on DaVita HealthCare Partners Inc. Nov 22 2013 

    More From Our Partners
    DaVita HealthCare Shares Slip Amid Raymond James Downgrade Jul 21 2014 - BENZINGA

    More From Other Websites
    Why DaVita HealthCare (DVA) Stock is Lower Today Jul 21 2014
    DaVita HealthCare Shares Slip Amid Raymond James Downgrade Jul 21 2014
    Today's Water-Logged And Getting Wetter Stock: DaVita HealthCare Partners (DVA) Jul 21 2014
    DaVita shares fall 4.8% on Raymond James downgrade Jul 21 2014
    DaVita downgraded to Market Perform from Outperform at Raymond James Jul 21 2014
    HealthCare Partners Announces Leadership Transition Jul 18 2014
    DaVita's Domestic Acquisitions Look Good, Debt Lingers Jul 18 2014
    [video] Suze Caller: Davita Jul 12 2014
    DaVita HealthCare Partners Inc. Schedules 2nd Quarter 2014 Investor Conference Call Jul 11 2014
    DaVita HealthCare Partners Inc. Schedules 2nd Quarter 2014 Investor Conference Call Jul 11 2014
    Dr. Martin Schreiber Joins DaVita Kidney Care Team Jul 09 2014
    DaVita Recognized as a Top Workplace by Bay Area News Group Jul 08 2014
    DaVita Recognized as a Top Workplace by Bay Area News Group Jul 08 2014
    DaVita Kidney Care Outperforms All Dialysis Providers in Quality Incentive Program Jul 02 2014
    The Zacks Analyst Blog Highlights: HSBC Holdings, UBS, JPMorgan Chase, Royal Bank of Scotland Group... Jul 02 2014
    Why DaVita Is a Sell Jul 01 2014
    DaVita Names Chief Medical Officer for Saudi Operations Jun 30 2014
    [video] Bullis Calls on FedEx and Norfolk Southern at Jefferies Jun 30 2014
    Analysts' Actions: Adobe DaVita, Guidewire Software Jun 30 2014
    DAVITA HEALTHCARE PARTNERS INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jun 26 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide